Vaccination hesitancy and the myth on mRNA-based vaccines in Italy in the COVID-19 era: Does urgency meet major safety criteria?

Coronavirus disease 2019 (COVID-19) vaccination campaign in Italy has started with a huge perplexity about vaccine efficacy, vaccine-borne adverse effects and vaccine clinical trial studies. In this commentary I tried to elucidate these issues, which represent a fundamental topic to be thoroughly addressed in COVID-19 pandemic.

Automated summary

This commentary aims to elucidate the perplexity surrounding the COVID-19 vaccination campaign in Italy, focusing on issues such as vaccine efficacy, adverse effects, and clinical trial studies, which are crucial in addressing the pandemic.